<DOC>
	<DOCNO>NCT00286000</DOCNO>
	<brief_summary>A multicentre phase II study evaluate result high dose simplify folfiri advanced colorectal cancer</brief_summary>
	<brief_title>High Dose Simplified Folfiri Advanced Colorectal Cancer : Multicentre Phase II Study</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Histologically cytologically proven adenocarcinoma colon rectum Documented progressive metastatic disease Patients least one unidimensional measurable lesion CTscan MRI accord response evaluation criterion solid tumour ( RECIST ) WHO performance status 0 1 Adequate laboratory value haematology , liverfunction renal function No previous chemotherapy metastatic colorectal cancer Past concurrent history neoplasm colorectal adenocarcinoma , except curatively treated cancer free disease 10 year . Bowel obstruction subobstruction . Crohn 's disease , ulcerative colitis . Other severe illness medical condition unstable cardiac disease treatment , myocardial infarction within 6 month inclusion . Active uncontrolled infection Other concomitant anticancer agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>